Article Versions Notes

Adamiak-Giera U, Jawień W, Pierzchlińska A, Białecka M, Kobierski JD, Janus T, Gawrońska-Szklarz B. Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications. Pharmaceutics. 2021; 13(9):1395. https://doi.org/10.3390/pharmaceutics13091395

Adamiak-Giera, Urszula, Wojciech Jawień, Anna Pierzchlińska, Monika Białecka, Jan Dariusz Kobierski, Tomasz Janus, and Barbara Gawrońska-Szklarz. 2021. "Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications" Pharmaceutics 13, no. 9: 1395. https://doi.org/10.3390/pharmaceutics13091395

Adamiak-Giera, U., Jawień, W., Pierzchlińska, A., Białecka, M., Kobierski, J. D., Janus, T., & Gawrońska-Szklarz, B. (2021). Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications. Pharmaceutics, 13(9), 1395. https://doi.org/10.3390/pharmaceutics13091395